• Fund Type: Open-End Fund
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Dreyfus Global Equity Income Fund

+ Add to Watchlist

DEQAX:US

12.70 USD 0.02 0.16%

As of 09:29:30 ET on 11/20/2014.

Snapshot for Dreyfus Global Equity Income Fund (DEQAX)

Year To Date: +4.23% 3-Month: -0.31% 3-Year: +12.54% 52-Week Range: 11.83 - 13.31
1-Month: +5.82% 1-Year: +6.23% 5-Year: +10.02% Beta vs FTWI01: 0.87

Mutual Fund Chart for DEQAX

No chart data available.
  • DEQAX:US 12.70
  • 1M
  • 1Y
Interactive DEQAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEQAX

Dreyfus Global Equity Income Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize total return. The Fund invest at least 80% of its assets in equity securities. The Fund seeks to focus on dividend-paying stocks of companies located in the developed capital markets, such as the USA, Canada, Japan, Australia, Hong Kong and Western Europe.

Inception Date: 10-18-2007 Telephone: 1-800-346-8893 Domestic
Managers: NICK CLAY / JAMES HARRIES
Web Site: www.dreyfus.com

Fundamentals for DEQAX

NAV (on 2014-11-20) 12.70
Assets (M) (on 2014-11-20) 300.57
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for DEQAX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-30) 0.09
Dividend Yield (ttm) 3.35

Fees & Expenses for DEQAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.50

Top Fund Holdings for DEQAX

Filing Date: 08/31/2014
Name Position Value % of Total
Reynolds American Inc 292,939 17,128,143 5.471%
Microsoft Corp 357,400 16,236,682 5.187%
Philip Morris International In 159,000 13,607,220 4.347%
Sysco Corp 265,255 10,034,597 3.205%
GlaxoSmithKline PLC 395,000 9,669,093 3.089%
Novartis AG 100,000 8,970,100 2.865%
Roche Holding AG 29,500 8,602,091 2.748%
Centrica PLC 1,590,000 8,430,938 2.693%
Orkla ASA 849,789 7,678,052 2.453%
Reed Elsevier NV 314,000 7,158,305 2.287%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil